(Press-News.org) A sensitive blood test being developed by a team of researchers at the University of Michigan Rogel Cancer Center shows promise for predicting whether patients with metastatic HPV-positive throat cancer will respond to treatment months earlier than standard imaging scans.
That's according to a study, published in Oncotarget, validating the test in a small group of patients with metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma -- a type of head and neck cancer that develops in the back of the mouth and in the throat.
If the test can quickly determine that a treatment approach isn't helping, it could allow doctors to seek out alternative therapies or clinical trials in a more timely manner. It could also potentially spare some patients months of toxic side effects from a treatment that isn't working.
"Currently, the only way doctors know if a treatment is working is for the patient to get an imaging scan every few months to see whether their tumors are shrinking," said oncologist Paul Swiecicki, M.D., one of the study's senior authors. "And this isn't fully accurate since some cancers show what we call pseudoprogression, where a successful treatment actually makes the tumors bigger before it shrinks them.
"Our goal was to develop a test that could tell us whether a treatment is likely to work after a single cycle," he continued.
The research comes amid a rising incidence of throat cancer caused by human papillomavirus infections, which are often spread through sexual activity. Once the cancer has recurred or spread within the body, patients typically only live for about one year. Furthermore, most of the available treatments, such as immunotherapy, work for less than 20% of patients and can have significant side effects.
The test is a form of "liquid biopsy" that looks for DNA shed by a patient's cancer cells into their bloodstream using a method known as digital droplet PCR, which can amplify minute amounts of DNA for analysis.
Development of the test was led by co-first authors Catherine Haring, M.D., an otolaryngology resident, and Chandan Bhambhani, Ph.D., a postdoctoral research fellow in the lab of senior study author Muneesh Tewari, M.D., Ph.D.
"We can actually identify DNA from a small tumor at the back of the throat circulating throughout the entire bloodstream," Haring said.
"From a single tube of blood, this technology can isolate a single copy of tumor DNA," Bhambhani added. "And quantifying the number of copies can tell us whether a patient's cancer is responding to treatment."
The study analyzed more than 100 samples taken over nearly two years from 16 patients with advanced cancer that was positive for HPV 16, one of the most common, high-risk types of HPV infection. Seven of the patients were treated with immunotherapy regimens. Eleven patients underwent treatment that included chemotherapy.
The researchers found that increasing levels of HPV-positive circulating tumor DNA after a course of treatment were a strong indicator that the cancer was not responding to the treatment. And that the tumor DNA could be detected months ahead of tumor growth that can be measured on imaging scans.
Swiecicki points to one of the patients in the study as an example.
The patient underwent chemotherapy treatment for about 200 days. Their HPV 16-positive circulating tumor DNA fell to nearly zero for the first 100 days and imaging scans showed the disease had stabilized. But copies of the HPV 16 DNA started to multiply in their blood between day 100 and day 200, when the disease progression was ultimately detected on imaging scans.
"In the future, the idea is that the test would give us a window of time -- about 100 days in this example -- to find alternative therapies or a clinical trial," Swiecicki said. "And this particular patient did have significant toxicities from the therapy, some of which potentially could have been avoided once it became clear the cancer was no longer responding to the treatment."
Senior study author Chad Brenner, Ph.D., an associate professor in the Department of Otolaryngology-Head and Neck Surgery, notes that scientists around the world have been working to develop similar tests. The success at U-M was the result of collaboration that involved clinicians as well as researchers with expertise in next-generation sequencing and in the genetics of head and neck cancer.
"Everybody talks about team science," added Tewari, a professor of internal medicine and of biomedical engineering, "but everybody involved in this effort contributed a unique piece. And U-M is a place that really embraces this spirit of interdisciplinary collaboration."
The blood test may also be useful for early detection of recurrence before the cancer is incurable. According to additional findings the research team recently described in the journal Oral Oncology, HPV circulating tumor DNA is in the blood of patients with early stage throat cancer. Retrospectively, the test was also able to identify recurrent disease in a patient more than a year before it was detected by with standard approaches.
Before treatment, the patient had significant levels of circulating tumor DNA in their blood, which dropped down to near zero in the months following treatment.
"We thought they were potentially cured," Brenner said. "We couldn't detect this biomarker at all."
But after six months, the level of circulating tumor DNA in their blood started to rise -- slowly at first and then more dramatically.
"Yet we weren't able to detect clinical signs of recurrence until after the two-year time point," Brenner noted. "So, our test was able to detect the first signals of recurrence a year and a half before it was evident on imaging scans."
While work to further optimize and validate the test continues, the team is partnering with other academic medical institutions to use the test to study the relationship between HPV-positive circulating tumor DNA and clinical outcomes in additional patients.
INFORMATION:
Disclosure: The study team has filed an invention disclosure on the DNA assay and the University of Michigan has filed for patent protection on the assay technology.
Additional authors on the two studies include Emily Bellile, Apurva Bhangale, Carol Bradford, Collin Brummel, Keith Casper, Avraham Eisbruch, Molly Heft Neal, Brittany Jewell, Kelly Malloy, Jonathan McHugh, Scott McLean, Michelle Mierzwa, Mark E. Prince, Andrew Rosko, Erin Sandford, Andrew Shuman, Matthew E. Spector, Ryan M. Spengler, Chaz Stucken and Francis P. Worden, all of U-M.
These studies were supported by grants from the National Cancer Institute (CA194536, P30CA046592).
Papers cited:
"Human Papilloma Virus Circulating Tumor DNA Assay Predicts Treatment Response in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma," Oncotarget. DOI: 10.18632/oncotarget.27992
"Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation," Oral Oncology. DOI: 10.1016/j.oraloncology.2021.105332
AMHERST, Mass. - As summer unfolds, more than 500 species of invasive plants will be taking root in fields, lawns, and gardens across the US. As plants continue to move north driven by climate change, the number of invasives will only increase. Unfortunately, inconsistent regulations that vary from state to state means that invasive plants have an edge on our attempts to control them. However, new research from the University of Massachusetts Amherst recently published in the Journal of Applied Ecology suggests that we already have an answer in hand - communication.
"We know that invasive plants are causing both ecological and economic harm in the US," says Emily Fusco, one of the paper's lead authors and a postdoctoral research fellow in the department of environmental conservation ...
OAK BROOK, Ill. - Researchers have developed an artificial intelligence (AI)-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment, according to a study published in Radiology: Artificial Intelligence. The model has the potential to aid in early detection of cognitive impairment at an individual level.
Amnestic mild cognitive impairment (aMCI) is a transition phase from normal aging to Alzheimer's disease (AD). People with aMCI have memory deficits that are more ...
A year-long Australian population study has found that full time workers employed by organisations that fail to prioritise their employees' mental health have a threefold increased risk of being diagnosed with depression.
And while working long hours is a risk factor for dying from cardiovascular disease or having a stroke, poor management practices pose a greater risk for depression, the researchers found.
The University of South Australia study, published in the British Medical Journal today, is led by UniSA's Psychosocial Safety Climate Observatory, the world's first research platform exploring workplace psychological health and safety.
Psychosocial safety climate (PSC) is the term used to describe management practices ...
In our future electrified world, the demand for battery storage is projected to be enormous, reaching to upwards of 2 to 10 terawatt-hours (TWh) of annual battery production by 2030, from less than 0.5 TWh today. However, concerns are growing as to whether key raw materials will be adequate to meet this future demand. The lithium-ion battery - the dominant technology for the foreseeable future - has a component made of cobalt and nickel, and those two metals face severe supply constraints on the global market.
Now, after several years of research led by Lawrence Berkeley National Laboratory (Berkeley Lab), scientists have made significant progress in developing battery cathodes using ...
Tokyo, Japan - Stem cell therapy is at the cutting edge of regenerative medicine, but until now researchers and clinicians have had to painstakingly evaluate stem cell quality by looking at each cell individually under a microscope. Now, researchers from Japan have found a way to speed up this process, using the power of artificial intelligence (AI).
In a study published in February in Stem Cells, researchers from Tokyo Medical and Dental University (TMDU) reported that their AI system, called DeepACT, can identify healthy, productive skin stem cells with the same accuracy that a human can.
Stem cells are able to develop into several different kinds of mature ...
A team of researchers developed a biomimetic mineralization of calcium carbonate using a multifunctional peptide template that can self-supply mineral sources, which in this case is a supply of carbonate ions, the precursor of calcium carbonate, and following the mechanism of biosynthesis of hard tissues by living organisms, called biomineralization, the ability to form hydrogels, which is modeled after the reaction environment of living organisms. Previous studies on mineralization have discussed the formation mechanism of inorganic crystals synthesized on ...
Current American Heart Association, European Society of Cardiology, and UK National Health Service guidelines recommend a 5-yearly health checks for screening of individuals at high cardiovascular disease risk. These health checks include measurement of major risk factors, such as systolic blood pressure, cholesterol profile, blood glucose, and smoking status.
If lifestyle interventions are unsuccessful in reducing risk factor levels, prevention guidelines recommend initiation of preventive medication therapies such as statins. However, current guidelines advice only using the latest ...
The results of the study were published in the journal "Neurology" on 19 May 2021 under the leadership of Professor Elena Enax-Krumova, holder of the endowed professorship of the German Social Accident Insurance (DGUV).
Nerve injuries: frequent complication after occupational accidents
Peripheral nerves refer to nerves that lie outside of the brain and spinal cord. They run throughout the entire body. These bundles of nerve fibres can be damaged in the event of blunt or sharp force trauma due to accidents, as well as during surgery. Injuries to the peripheral nerves are a frequent complication, particularly after occupational accidents. Patients often suffer from motor and sensory disorders in the affected area of the body. These can lead to persistent complaints and ...
Beware of those snack attacks. A new study in Appetite has confirmed the small luxuries, from sweets and chocolate to salty treats, have helped to lift our spirits - and kilojoule intake - during COVID-19 lockdowns.
Researchers in England and Australia have gathered evidence about similar experiences in the UK and Victoria, Australia to warn about the effect of extended pandemic lockdowns on our eating behaviours.
While time at home provides more time for healthy food preparation, intake of high-energy density foods (HED) has risen for some - presenting at-risk adults with the prospect of managing weight gain, the psychology researchers warn.
"The ...
The response times of footballers is slowed down when part of the kit worn by both teams is of the same colour, a new study shows.
The research from the University of York revealed that when players have any kit colour clash - either shirt or shorts - it takes them twice as long to find a fellow player on the pitch.
Study authors are calling for a change in the laws of the game or for clearer guidance.
Researchers used two experiments to investigate how kit variations affect the visual search for teammates. Their first experiment confirmed that a ...
